XML 140 R123.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule I - Condensed Financial Information of Parent Company - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net income (loss) for the period $ (96,197) $ (27,571) $ 3,364
Excess tax benefits on share-based compensation expense 0 (193) (1,554)
Stock-based compensation 8,134 7,599 4,592
Deferred income taxes (recovery) (13,040) (6,981) (1,328)
Amortization of discontinued cash flow hedge (1,144) (761) 0
Loss (gain) on change in the fair value of forward contracts 1,624 281 606
Accounts receivable (3,802) (3,825) 1,586
Prepaid expenses and deposits (382) 3,981 (3,974)
Income taxes recoverable 734 3,355 (1,394)
Accounts payable (5,319) 6,754 4,068
Accrued liabilities 9,044 7,411 4,857
Customer deposits 3,552 (1,191) 645
Net cash provided by (used in) operating activities (4,771) 19,876 29,637
Proceeds received on exercise of stock options 0 1,096 4,818
Net cash (used in) provided by financing activities 178,836 132,007 73,135
Acquisition of intangible assets (528) (782) (774)
Net cash used in investing activities (92,583) (137,492) (101,978)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents 81,482 14,391 794
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of year 23,496 9,105 8,311
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of year 104,978 23,496 9,105
Parent Company [Member]      
Net income (loss) for the period (96,197) (27,571) 3,364
Excess tax benefits on share-based compensation expense 0 (193) (1,554)
Stock-based compensation 6,035 5,779 4,592
Deferred income taxes (recovery) (11,804) (6,689) (1,251)
Amortization of discontinued cash flow hedge (1,144) (761) 0
Loss (gain) on change in the fair value of forward contracts 1,624 281 0
Equity in undistributed earnings of subsidiaries 97,150 25,348 (8,486)
Accounts receivable 381 (482) 0
Prepaid expenses and deposits (82) (49) (191)
Income taxes recoverable 1,208 532 108
Accounts payable (492) 507 102
Accrued liabilities 195 196 254
Customer deposits 0 (1) 0
Net cash provided by (used in) operating activities (3,126) (3,103) (3,062)
Net proceeds received from (paid to) subsidiaries 6,280 1,101 (1,650)
Proceeds received on exercise of stock options 0 1,096 4,431
Net cash (used in) provided by financing activities 6,280 2,197 2,781
Investment in unrelated company 0 (2,012) 0
Acquisition of intangible assets 0 0 (59)
Net cash used in investing activities 0 (2,012) (59)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents 3,154 (2,918) (340)
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of year 3,897 6,815 7,155
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of year $ 7,051 $ 3,897 $ 6,815